Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 3 February 2026

Ball stock jumps nearly 9% after earnings beat, $900 million 2026 cash-flow goal in sight

Ball stock jumps nearly 9% after earnings beat, $900 million 2026 cash-flow goal in sight

Ball Corp shares jumped 8.9% to $61.75 after reporting fourth-quarter adjusted earnings of $0.91 a share on $3.35 billion in sales, both above analyst estimates. Global aluminum-packaging shipments rose 6%. The company forecast over 10% comparable profit growth in 2026 and warned of about $35 million in direct tariff costs. Ball completed an 80% purchase of Benepack for €184 million.
3 February 2026
··
AI disruption fear drags Nasdaq lower as Alphabet, Amazon earnings loom

AI disruption fear drags Nasdaq lower as Alphabet, Amazon earnings loom

U.S. stocks dropped Tuesday, with the S&P 500 down 1.46% and the Nasdaq off 2.17% as investors worried AI could pressure software makers’ margins. PayPal plunged 19% after a CEO change and weak outlook, while Walmart reached a $1 trillion market value. The 10-year Treasury yield rose to 4.287%. The House narrowly passed a bill to end the government shutdown.
3 February 2026
··········
Adobe stock price slides on AI disruption jitters; investors look to March earnings call

Adobe stock price slides on AI disruption jitters; investors look to March earnings call

Adobe shares fell 7.1% to $272.62 Tuesday, leading a sharp sell-off in software stocks after Anthropic launched a new AI legal tool. Investors cited fears that generative AI could disrupt established players and pressure margins. Adobe will report earnings March 12, with focus on AI monetization and demand trends.
3 February 2026
····
Stocks Slide as AI Disruption Jitters Hit Tech — Earnings Wave Looms

Stocks Slide as AI Disruption Jitters Hit Tech — Earnings Wave Looms

U.S. stocks fell Tuesday, with the Nasdaq down nearly 2% as tech and software shares slid on AI disruption fears. Alphabet and Amazon dipped ahead of earnings, while Nvidia and Microsoft also declined. Teradyne jumped over 20% on a strong forecast. Labor-market data was delayed by the ongoing partial government shutdown.
3 February 2026
········
Carpenter Technology stock price jumps nearly 8% as raised outlook keeps CRS in focus

Carpenter Technology stock price jumps nearly 8% as raised outlook keeps CRS in focus

Carpenter Technology shares jumped 7.8% to $335.75 Tuesday after the company raised its full-year profit outlook and reported record second-quarter operating income of $155.2 million. Trading volume reached 1.2 million shares by mid-afternoon. The company cited strong aerospace and defense demand and projected Q3 operating income of $177 million to $182 million. Investors await third-quarter results due April 23.
3 February 2026
··
Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit

Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit

Qualcomm shares fell about 5% to $144.94 in afternoon trading Tuesday, underperforming a broader chip stock decline. The drop followed news of a senior engineering executive’s exit and a cautious analyst note ahead of Wednesday’s quarterly earnings report. The iShares Semiconductor ETF slipped 3.5%, while Nvidia dropped over 4%. Qualcomm will hold its earnings call at 4:45 p.m. ET on Feb. 4.
3 February 2026
···
Boston Scientific stock slips today: what to know before earnings and key Watchman trial data

Boston Scientific stock slips today: what to know before earnings and key Watchman trial data

Boston Scientific (BSX.N) slipped 0.7% to $91.20 in Tuesday afternoon trading, with about 10.4 million shares exchanged. CEO Michael F. Mahoney filed to potentially sell up to 160,901 shares valued at $15 million. The company reports fourth-quarter earnings Wednesday morning. Investors await late-March CHAMPION-AF trial results for the Watchman device.
3 February 2026
··
Teradyne stock jumps 11% as AI chip-testing boom drives upbeat forecast for TER shares

Teradyne stock jumps 11% as AI chip-testing boom drives upbeat forecast for TER shares

Teradyne shares jumped 11% to $277.63 Tuesday after the company forecast first-quarter revenue of $1.15–$1.25 billion, topping analyst estimates. Fourth-quarter revenue reached $1.083 billion with non-GAAP earnings of $1.80 per share. The company cited strong AI chip demand. Cantor Fitzgerald maintained its Overweight rating and $270 price target.
3 February 2026
··
Robinhood stock sinks nearly 10% as Bitcoin slides below $80,000 ahead of Feb. 10 earnings

Robinhood stock sinks nearly 10% as Bitcoin slides below $80,000 ahead of Feb. 10 earnings

Robinhood shares fell 9.62% to $89.91 Monday as bitcoin slumped and trading volume surged to 59 million shares, 136% above average. The drop comes a week before Robinhood’s quarterly earnings report, set for Feb. 10. U.S. stocks closed higher, with the Dow up 1.1%. Coinbase declined for a tenth straight session despite bitcoin rebounding from weekend lows.
3 February 2026
··
Dow drops nearly 430 points as tech selloff deepens; Amazon, Alphabet earnings loom

Dow drops nearly 430 points as tech selloff deepens; Amazon, Alphabet earnings loom

The Dow Jones Industrial Average fell 429.92 points, or 0.87%, to 48,977.74 on Tuesday, with the S&P 500 down 1.04% and the Nasdaq off 1.68%. Sharp declines in IBM, Salesforce, and software stocks weighed on the Dow, while PayPal plunged 19% after its CEO was ousted and its profit forecast missed estimates. Palantir jumped 6.9% on strong sales. Investors await earnings from Alphabet and Amazon this week.
3 February 2026
········
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next

DaVita shares rose nearly 20% to $132.98 after the company projected 2026 adjusted earnings per share of $13.60–$15.00, above analyst estimates. Fourth-quarter adjusted EPS reached $3.40 on revenue of $3.62 billion, both topping forecasts. The company cited higher reimbursement rates and a seasonal boost from flu vaccines. DaVita flagged a $40 million hit in 2026 from expiring ACA subsidies.
3 February 2026
··
PepsiCo stock jumps as Lay’s and Doritos price cuts hit shelves after earnings beat

PepsiCo stock jumps as Lay’s and Doritos price cuts hit shelves after earnings beat

PepsiCo shares rose 3.7% to $160.99 Tuesday after the company cut U.S. snack prices and beat quarterly revenue and earnings forecasts. The company raised its dividend, confirmed 2026 targets, and approved a new $10 billion share buyback. Snack prices on brands like Lay’s and Doritos are dropping up to 15% this week. Investors are watching if lower prices will lift North American volumes before the Super Bowl.
3 February 2026
··
KLA stock slides as chip-equipment names retreat; shutdown jitters and megacap earnings in focus

KLA stock slides as chip-equipment names retreat; shutdown jitters and megacap earnings in focus

KLA shares fell 4.5% to $1,346.85 by midday Tuesday, underperforming other chip-equipment stocks as tech shares broadly declined. The partial U.S. government shutdown delayed key labor-market data, adding uncertainty for investors. Alphabet and Amazon earnings this week are in focus for signals on AI and cloud spending.
3 February 2026
········
Eli Lilly stock slips as obesity-drug price cuts and rival data set up Feb. 4 earnings

Eli Lilly stock slips as obesity-drug price cuts and rival data set up Feb. 4 earnings

Eli Lilly shares fell 1.4% to $1,029.99 by midday Tuesday as U.S. prices for GLP-1 obesity drugs dropped sharply, prompting analysts to cut long-term forecasts. Novo Nordisk and Pfizer reported strong weight-loss data for rival drugs this week, intensifying competition. Investors await Lilly’s earnings update Wednesday for signals on pricing, demand, and supply outlooks.
3 February 2026
·····
1 … 14 15 16 17 18 … 202

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop